Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.48
-2.0%
$0.59
$0.43
$2.04
$8.82M-2.71102,666 shs65,938 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$3.53
$3.57
$2.58
$55.90
$2.25M0.2155,799 shs10,762 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00%-5.43%-19.48%-22.99%-62.23%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.00%+0.86%-22.93%-9.72%-89.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$0.48
-2.0%
$0.59
$0.43
$2.04
$8.82M-2.71102,666 shs65,938 shs
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
$3.53
$3.57
$2.58
$55.90
$2.25M0.2155,799 shs10,762 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00%-5.43%-19.48%-22.99%-62.23%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.00%+0.86%-22.93%-9.72%-89.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
1.50
ReduceN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BFRG and SHPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E)Sell (E+)
8/21/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+)Sell (E)
8/5/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E)Sell (E+)
8/3/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
UpgradeSell (E+)Sell (D-)
7/17/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
Reiterated RatingSell (E+)
7/17/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+)Sell (E)
6/30/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
UpgradeSell (E)Sell (E+)
6/26/2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
UpgradeHold
6/15/2026
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
DowngradeSell (E+)Sell (E)
(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$120K73.53N/AN/A$0.19 per share2.50
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/A$11.14 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.50M-$0.46N/AN/AN/AN/A-150.36%-127.98%11/13/2026 (Estimated)
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
-$11.72M-$47.70N/AN/AN/AN/A-408.34%-138.15%N/A

Latest BFRG and SHPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$0.11-$0.07+$0.04-$0.07$0.22 million$0.22 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
10.57
10.57
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
N/A
0.30
0.30

Institutional Ownership

CompanyInstitutional Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
4.58%

Insider Ownership

CompanyInsider Ownership
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
14.70%
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
0.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
418.54 million15.82 millionNot Optionable
Shuttle Pharmaceuticals Holdings, Inc. stock logo
SHPH
Shuttle Pharmaceuticals
5640,000635,000Not Optionable

Recent News About These Companies

SHPH Share News Today
Shuttle Pharmaceuticals Holdings Inc SHPH
Shuttle Pharmaceuticals Holdings, Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$0.48 -0.01 (-1.98%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.49 +0.01 (+2.96%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Shuttle Pharmaceuticals stock logo

Shuttle Pharmaceuticals NASDAQ:SHPH

$3.53 0.00 (0.00%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.44 -0.09 (-2.41%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.